is ozempic compounded semaglutide Makers of Wegovy, threatened by FDA move As demand grows for GLP-1
Description
Hills research does suggest that, while the API is a minor cost component compared to the pen in an injectable formulation, the need to dose daily for a higher API load in a pill makes orals pricier to manufacture than injectables, further raising the competitive advantage of manufacturing small molecule alternatives, such as Lillys orforglipron
The GLP-1 Solution: A Complete Program to Maximize Your Weight and Fat Loss Results [McDonald, Lyle, Singh, Sumi] on Amazon.com
Read a full license here
Premiums are shifting, and the government contribution varies
